Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant

NCT07634536 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myeloproliferative Neoplasm
Myelodysplastic Syndromes

Interventions

RADIATION: VMAT-Based Total Marrow and Lymphoid Irradiation (TMLI)
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)
DRUG: Mycophenolate mofetil (MMF)
DRUG: Tacrolimus

Sponsor

Stanford University